144 related articles for article (PubMed ID: 21353162)
1. Cetuximab-related radiation dermatitis in head-and-neck cancer patients: in regard to Studer et al. (Int J Radiat Oncol Biol Phys in press).
Russi EG; Numico G; Merlano MC; Pinto C
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1278; author reply 1278-9. PubMed ID: 21353162
[No Abstract] [Full Text] [Related]
2. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
[TBL] [Abstract][Full Text] [Related]
3. StatBite: Radiation therapy plus cetuximab: skin reactions from 71 head and neck cancer patients from 11 institutions in Europe.
J Natl Cancer Inst; 2010 Jan; 102(2):75. PubMed ID: 20054017
[No Abstract] [Full Text] [Related]
4. Re-irradiation for recurrent head and neck cancer: in regard to Lee et Al. (Int j radiat oncol biol phys 2007;68:731-740).
Nieder C
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1652-3; author reply 1653. PubMed ID: 18035224
[No Abstract] [Full Text] [Related]
5. Severe cutaneous toxicity during concomitant radiotherapy and cetuximab treatment of head and neck cancer.
Vano-Galvan S; de las Heras E; Harto A; Jaen P
Eur J Dermatol; 2008; 18(4):471-2. PubMed ID: 18573734
[No Abstract] [Full Text] [Related]
6. In regards to Barkati et al. (Int J Radiat Oncol Biol Phys 2010;76:410-416).
Christiansen H; Rödel RM; Matthias C; Hess CF; Wolff HA
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):639-40. PubMed ID: 20542387
[No Abstract] [Full Text] [Related]
7. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes.
Giro C; Berger B; Bölke E; Ciernik IF; Duprez F; Locati L; Maillard S; Ozsahin M; Pfeffer R; Robertson AG; Langendijk JA; Budach W
Radiother Oncol; 2009 Feb; 90(2):166-71. PubMed ID: 18977050
[TBL] [Abstract][Full Text] [Related]
8. Pattern analysis of acute mucosal reactions in patients with head and neck cancer treated with conventional and accelerated irradiation. In regard to Wygodaa, et al. (Int J Radiat Oncol Biol Phys 2008;73:384-390).
Liao XB; Yan SX; Qiu XY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1306; author reply 1306. PubMed ID: 19545795
[No Abstract] [Full Text] [Related]
9. In regard to Lee et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. (Int J Radiat Oncol Biol Phys 2003;57:49-60).
Yao M; Dornfeld KJ; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1639; author reply 1639-40. PubMed ID: 15050350
[No Abstract] [Full Text] [Related]
10. Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191-2200.
Russi EG; Bensadoun RJ; Merlano MC; Bourhis J; Ricardi U; Giralt J; Pinto C; Budach W; Corvò R; Lacouture ME; Bernier J
Ann Oncol; 2013 Sep; 24(9):2463-5. PubMed ID: 23897703
[No Abstract] [Full Text] [Related]
11. Severe desquamation with skin necrosis: a distinct pattern of skin toxicity secondary to head and neck irradiation with concomitant cetuximab.
Billan S; Abdah-Bortnyak R; Kuten A
Isr Med Assoc J; 2008 Mar; 10(3):247. PubMed ID: 18494248
[No Abstract] [Full Text] [Related]
12. Randomized trial on two types of thermoplastic masks for patient immobilization during radiation therapy for head-and-neck cancer: In regard to Sharp et al. (Int J Radiat Oncol Biol Phys 2005;61:250-256).
Roques T; Dagless M; Tomes J
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):942; author reply 943. PubMed ID: 15936583
[No Abstract] [Full Text] [Related]
13. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer: in regard to Schoenfeld et al. (Int J Radiat Oncol Biol Phys 2008;71:377-385).
Studer GM; Glanzmann C
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1271-2; author reply 1272. PubMed ID: 18954722
[No Abstract] [Full Text] [Related]
14. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia: in regard to Ringash et al. (Int J Radiat Oncol Biol Phys 2005;61:1403-1407).
Momm F; Lutterbach J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):969; author reply 969-70. PubMed ID: 16199327
[No Abstract] [Full Text] [Related]
15. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome: in regard to Evans et al. (Int J Radiat Oncol Biol Phys 2007;69:1024-1031).
Bussink J; van der Kogel AJ; Kaanders JH
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1616. PubMed ID: 18374238
[No Abstract] [Full Text] [Related]
16. Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions: in regard to Beuve et al. (Int J Radiat Oncol Biol Phys, In Press).
Scholz M; Elsässer T
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):302-3; author reply 303. PubMed ID: 18722283
[No Abstract] [Full Text] [Related]
17. Hypofractionated radiotherapy plus cetuximab in locally advanced head and neck cancer.
Teoh DC; Rodger S; Say J; Hartley A
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):717. PubMed ID: 18757187
[No Abstract] [Full Text] [Related]
18. In response to Dr. Merav A. Ben-David et al. ("Lack of osteoradionecrosis of the mandible after IMRT," Int J Radiat Oncol Biol Phys 2007:In Press).
Studer G; Graetz KW; Glanzmann C
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1583-4. PubMed ID: 17674994
[No Abstract] [Full Text] [Related]
19. Cetuximab with concurrent chemoradiation for esophagogastric cancer: in regard to Safran et al. (Int J Radiat Oncol Biol Phys 2008;70:391-395).
Adenis A; Mariette C; Mirabel X; Seitz JF; Conroy T
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):958-9. PubMed ID: 19014786
[No Abstract] [Full Text] [Related]
20. A marginal issue: in regard to Wolden et al. (Int J Radiat Oncol Biol Phys 2005;61:1432-1438).
Scarbrough TJ; Thomas CR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):647-8; author reply 648-9. PubMed ID: 16168860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
